Aeglea BioTherapeutics, Inc. (AGLE) SEC filings

AGLE SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the AGLE overview →

10 measured AGLE SEC filing events.

DateHeadlineEvent5-minTo close
Form 8-K Spyre Therapeutics, Inc. For: Dec 07SEC filing · Form 8-K——
Form 8-K Spyre Therapeutics, Inc. For: Nov 22SEC filing · Form 8-K——
Form 8-K Aeglea BioTherapeutics, For: Nov 21SEC filing · Form 8-K—+4.54%
Form EFFECT Aeglea BioTherapeutics,SEC filing · Form EFFECT+0.19%-7.26%
Form 8-K Aeglea BioTherapeutics, For: Nov 15SEC filing · Form 8-K+0.00%-7.24%
Form S-1/A Aeglea BioTherapeutics,SEC filing · Form S-1+0.00%-7.24%
Form 10-Q Aeglea BioTherapeutics, For: Sep 30SEC filing · Form 10-Q+0.00%+2.82%
Form 8-K Aeglea BioTherapeutics, For: Nov 09SEC filing · Form 8-K+0.00%+2.82%
Form DEF 14A Aeglea BioTherapeutics, For: Nov 21SEC filing · Form DEF+0.00%-5.50%
Form 8-K Aeglea BioTherapeutics, For: Oct 24SEC filing · Form 8-K—-6.53%
Get an email when AGLE moves on news →
Keep exploring

More AGLE: earnings → · analyst actions → · AGLE overview →

Other Healthcare names and their SEC filings

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.